AI assistant
Sending…
Genscript Biotech Corporation — Board/Management Information 2015
Dec 29, 2015
49993_rns_2015-12-29_3c8b57fd-ea86-49e2-a9bc-b690702b10f1.pdf
Board/Management Information
Open in viewerOpens in your device viewer
Genscript Biotech Corporation 金斯瑞生物科技股份有限公司*
(incorporated in the Cayman Islands with limited liability)
(Stock Code: 1548)
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
The members of the board of directors (the “ Board ”) of Genscript Biotech Corporation are set out below:
Executive Directors
Dr. ZHANG Fangliang ( Chairman and Chief Executive Officer ) Ms. WANG Ye ( Chief Operating Officer )
Mr. MENG Jiange ( Vice President of Finance )
Non-executive Directors
Dr. WANG Luquan Mr. HUANG Zuie-Chin Mr. PAN Yuexin
Independent Non-executive Directors
Mr. GUO Hongxin Mr. DAI Zumian Ms. ZHANG Min
The Board has established three committees, and the Directors are serving on the respective committees as below:
| committees as below: | |||
|---|---|---|---|
| Board Committee**Director ** | AuditCommittee | RemunerationCommittee | NominationCommittee |
| Dr. ZHANG Fangliang | / | / | C |
| Ms. WANG Ye | / | M | / |
| Mr. GUO Hongxin | M | C | / |
| Mr. DAI Zumian | C | M | M |
| Ms. ZHANG Min | M | / | M |
Notes:
C: Chairman of the relevant Board committees M: Member of the relevant Board committees
Hong Kong, 30 December 2015
- For identification purposes only
- 1 -
More from Genscript Biotech Corporation
Regulatory Filings
2026
May 22
Report Publication Announcement
2026
May 12
Regulatory Filings
2026
May 6
Earnings Release
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 13
Proxy Solicitation & Information Statement
2026
Apr 13
Proxy Solicitation & Information Statement
2026
Apr 13
Environmental & Social Information
2026
Apr 13
Annual Report
2026
Apr 13
Governance Information
2026
Apr 10